Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up - TradingView
Merck→Terns Pharmaceuticals
Mar 26, 2026
Track pharmacy acquisitions and investments within the healthcare sector.
Merck→Terns Pharmaceuticals
Mar 26, 2026
Merck→Terns Pharmaceuticals
Mar 25, 2026
Merck→Terns Pharmaceuticals
Mar 25, 2026
Gilead Sciences→Ouro Medicines
Mar 23, 2026
Novartis→Pikavation Therapeutics
Mar 20, 2026
Sycamore Partners→Walgreens
Feb 28, 2026
Cigna→CarepathRx
Feb 26, 2026
Sycamore Partners→Walgreens
Feb 24, 2026
RedSail Technologies→PrimeRx
Feb 17, 2026
Ampersand Capital Partners→Purna Pharmaceuticals
Feb 12, 2026
Sanofi→Dynavax
Feb 10, 2026
Adenia Partners→Parkville Pharmaceuticals
Jan 26, 2026
BioCryst Pharmaceuticals→Astria Therapeutics
Jan 23, 2026
GSK→Rapt Therapeutics
Jan 20, 2026
Torrent Pharma→JB Chemicals
Jan 9, 2026
Eli Lilly→Ventyx Biosciences
Jan 8, 2026
PAI Pharma→Nivagen Pharmaceuticals
Jan 6, 2026